A carregar...
Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer
BACKGROUND: Trastuzumab has been prevailingly accepted as a beneficial treatment for gastric cancer (GC) by targeting human epidermal growth factor receptor 2 (HER2)-positive. However, the therapeutic resistance of trastuzumab remains a major obstacle, restricting the therapeutic efficacy. Therefore...
Na minha lista:
| Publicado no: | World J Surg Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6106878/ https://ncbi.nlm.nih.gov/pubmed/30134903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-018-1475-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|